Strand Therapeutics Inc.
Biotechnology · Boston, MA
BiotechnologySEC Form D
Strand Therapeutics Inc. filed a Form D with the U.S. Securities and Exchange Commission on March 17, 2026, reporting $108,099,927 raised toward a $120,099,940 offering.
Incorporated in Delaware and based in Boston, MA, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Strand Therapeutics Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Jacob BecraftExecutive Officer · Director · Promoter
- Tasuku KitadaExecutive Officer · Director · Promoter
- Ala AlenaziDirector
- Pegah EbrahimiDirector
- Jory BellDirector
- Jeb KeiperDirector
- Samta KunduExecutive Officer
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$10.0MRaised